Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics

Alisha Bhanot; Rosie C Vincent; TJ Peters; Matthew J Ridd

doi:10.1111/ced.14934

Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics

Alisha Bhanot, Rosie C Vincent, TJ Peters, Matthew J Ridd^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter (Academic Journal) › peer-review

9 Citations (Scopus)

110 Downloads (Pure)

Abstract

The HOME (Harmonising Outcome Measures for Eczema) initiative seeks to standardise outcome measures in trials of eczema treatments.1 RECAP (Recap for atopic eczema) is a seven-item HOME recommended patient reported outcome measure of eczema control.2 The total score of RECAP is from 0 to 28, with a greater score indicating poorer eczema control. In an online survey of 382 participants, RECAP was found to have good validity and reliability.3 However, validity and reliability can vary by both population and setting.

Original language	English
Pages (from-to)	440-442
Number of pages	3
Journal	Clinical and Experimental Dermatology
Volume	47
Issue number	2
Early online date	23 Oct 2021
DOIs	https://doi.org/10.1111/ced.14934
Publication status	Published - 1 Feb 2022

Access to Document

10.1111/ced.14934

Full-text PDF (accepted author manuscript)
This is the accepted author manuscript (AAM). The final published version (version of record) is available online via Wiley at 10.1111/ced.14934. Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 333 KBLicence: Unspecified

Handle.net

Persistent link

Cite this

@article{9da82634ed5b437189f6651e4d27cd94,

title = "Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics",

abstract = "The HOME (Harmonising Outcome Measures for Eczema) initiative seeks to standardise outcome measures in trials of eczema treatments.1 RECAP (Recap for atopic eczema) is a seven-item HOME recommended patient reported outcome measure of eczema control.2 The total score of RECAP is from 0 to 28, with a greater score indicating poorer eczema control. In an online survey of 382 participants, RECAP was found to have good validity and reliability.3 However, validity and reliability can vary by both population and setting.",

author = "Alisha Bhanot and Vincent, {Rosie C} and TJ Peters and Ridd, {Matthew J}",

year = "2022",

month = feb,

day = "1",

doi = "10.1111/ced.14934",

language = "English",

volume = "47",

pages = "440--442",

journal = "Clinical and Experimental Dermatology",

issn = "0307-6938",

publisher = "Blackwell Scientific Publications",

number = "2",

}

TY - JOUR

T1 - Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics

AU - Bhanot, Alisha

AU - Vincent, Rosie C

AU - Peters, TJ

AU - Ridd, Matthew J

PY - 2022/2/1

Y1 - 2022/2/1

N2 - The HOME (Harmonising Outcome Measures for Eczema) initiative seeks to standardise outcome measures in trials of eczema treatments.1 RECAP (Recap for atopic eczema) is a seven-item HOME recommended patient reported outcome measure of eczema control.2 The total score of RECAP is from 0 to 28, with a greater score indicating poorer eczema control. In an online survey of 382 participants, RECAP was found to have good validity and reliability.3 However, validity and reliability can vary by both population and setting.

AB - The HOME (Harmonising Outcome Measures for Eczema) initiative seeks to standardise outcome measures in trials of eczema treatments.1 RECAP (Recap for atopic eczema) is a seven-item HOME recommended patient reported outcome measure of eczema control.2 The total score of RECAP is from 0 to 28, with a greater score indicating poorer eczema control. In an online survey of 382 participants, RECAP was found to have good validity and reliability.3 However, validity and reliability can vary by both population and setting.

U2 - 10.1111/ced.14934

DO - 10.1111/ced.14934

M3 - Letter (Academic Journal)

C2 - 34524696

SN - 0307-6938

VL - 47

SP - 440

EP - 442

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

IS - 2

ER -

Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics

Abstract

Access to Document

Handle.net

Fingerprint

Cite this